S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
CC
INSIDER · 2 COMPANIES · 10% OWNER

Coastlands Capital LP

Every open-market transaction filed under this name, Nov 9 to Nov 17. The same name appears at more than one issuer; filings don’t say whether it’s one person.

Filings
6
6 buys · 0 sells
Bought
$1.4M
open market, at cost
Sold
—
includes scheduled sales
Buys since
−5.1%
avg move from buy price, 6 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 17KTTAPasithea Therapeutics Corp.10% ownerBuy875,000$0.47$411K+8.7%
Nov 17BOLTBolt Biotherapeutics, Inc.10% ownerBuy20,000$5.75$115K−11.3%
Nov 16KTTAPasithea Therapeutics Corp.10% ownerBuy583,083$0.50$291K+2.4%
Nov 16BOLTBolt Biotherapeutics, Inc.10% ownerBuy33,094$5.89$195K−13.4%
Nov 13KTTAPasithea Therapeutics Corp.10% ownerBuy209,431$0.50$104K+3.1%
Nov 9BOLTBolt Biotherapeutics, Inc.10% ownerBuy50,000$6.38$319K−20.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.